Preventive migraine therapy: from clinical recommendations to clinical practice
Abstract
The article reviews indications and basic principles of migraine preventive treatment. Preventative drug selection should be based on the evidence from randomized clinical trials, the drug's mode of action and potential adverse events, as well as migraine comorbidities. Monotherapy is preferable and should be aimed at reducing headache frequency and treatment of comorbid conditions.
About the Authors
E. G. Filatova
First Moscow State Medical University n.a. I. M. Sechenov; Clinic of headache and vegetative disorders named after academician A. Vein
Russian Federation
Russian Federation
N. V. Latysheva
First Moscow State Medical University n.a. I. M. Sechenov; Clinic of headache and vegetative disorders named after academician A. Vein
Russian Federation
Russian Federation
References
1. Артеменко А. Р., Куренков А. А., Антипова О. С. «Диагностика и лечение хронической мигрени». Москва. Горячая линия - Телеком, 2014, 206 с.
2. Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 2012; 52: 1456-1470.
3. Куцемелов И. Б., Табеева Г. Р. Эпидемиология первичных головных болей. Боль, 2004; 4 (5): 25-31.
4. Осипова В. В. Головные боли. В: Боль (практическое руководство для врачей) / Под редакцией Н. Н. Яхно, М. А. Кукушкина. М.: Издательство РАМН, 2011. 512 с.
5. Blumenfeld A., Varon S., Wilcox T., Buse D., Kawata A., Manack A., Lipton R. (2010). Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia, 31 (3), 301-315.
6. Dimatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004; 42: 200-209.
7. V. Golovacheva, V. Parfenov, G. Tabeeva, V. Osipova. Combined cognitive-behavioral and pharmacological therapies for chronic migraine and chronic tension-type headache: are treatment responses different? Cephalalgia, 2015, Vol. 35 (6S) 272. DOI: 10.1177/0333102415581304.
8. Steiner TJ, MacGregor EA, Davies PTG. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication overuse headache. British Association for the Study of Headache, 3rd edn. 2007: 1-52 3.
9. Evers S, Afra J, Frese A et al. EFNS guideline on the drug treatment of migraine-report of an EFNS task force. Eur J Neurol2009, 16:968-981.
10. Осипова В. В., Филатова Е. Г., Артеменко А. Р. с соавт. Диагностика и лечение мигрени: рекомендации российских экспертов, Журнал неврологии и психиатрии им. Корсакова, 1, 2017; Вып. 2, с. 28-42. doi: 10.17116/jnevro20171171228-42.
11. V. Osipova, I. Ayzenberg, A. Amelin, S. Tarasova, A. Sergeev, G. Tabeeva. The highest prevalence of CDH in Russia: why? Cephalalgia, 2015, Vol. 35 (6S) 287. DOI: 10.1177/0333102415581304.
12. Nestoriuc Y, Martin A, Rief W, Andrasik F. Bio-feedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback 2008, 33: 125-140.
13. Наприенко М. В., Аатышева Н. В., Филатова Е. Г. Новые возможности лечения хронической ежедневной головной боли, Журнал неврологии и психиатрии им С. С. Корсакова, 2010, т. 110, № 1, стр. 49-54.
Review
For citations:
Filatova E.G., Latysheva N.V. Preventive migraine therapy: from clinical recommendations to clinical practice. Medical alphabet. 2018;2(17):43-46. (In Russ.)
Views:
385
Email this article 